The newly confirmed Commissioner of the Food and Drug Administration (FDA), Dr. Robert M. Califf, stated the backlog of some 4,300 generic drugs awaiting approval is costing consumers billions of dollars each year.
The pharmaceutical industry blames the FDA’s – which regulates up to 25 cents of every dollar spent by U.S. consumers – application process and the department’s underfunding for the backlog but FDA states the companies often submit poor applications. Read article here….
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.